InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

InspireMD, Inc.

NSPR Clue Score57
United States Fiscal year ends December CIK 0001433607
$0.52 +8.54% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.52 −86.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.9Operating income−7.6Net income−8.5Fiscal year 2017Revenue2.8 +45.8%Operating income−8.2Net income−8.4Fiscal year 2018Revenue3.6 +30.4%Operating income−7.6Net income−7.2Fiscal year 2019Revenue3.7 +3.3%Operating income−9.8Net income−10.0Fiscal year 2020Revenue2.5 −33.2%Operating income−10.4Net income−10.5Fiscal year 2021Revenue4.5 +80.9%Operating income−14.7Net income−14.9Fiscal year 2022Revenue5.2 +15.0%Operating income−18.7Net income−18.5EPS, diluted−2.35Fiscal year 2023Revenue6.2 +20.0%Operating income−21.1Net income−19.9EPS, diluted−0.82Fiscal year 2024Revenue7.0 +13.0%Operating income−33.5Net income−32.0EPS, diluted−0.76Fiscal year 2025Revenue9.0 +28.1%Operating income−49.6Net income−48.8EPS, diluted−0.76
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.9 2.8 3.6 3.7 2.5 4.5 5.2 6.2 7.0 9.0
Growth +45.8% +30.4% +3.3% −33.2% +80.9% +15.0% +20.0% +13.0% +28.1%
Operating income −7.6 −8.2 −7.6 −9.8 −10.4 −14.7 −18.7 −21.1 −33.5 −49.6
Net income −8.5 −8.4 −7.2 −10.0 −10.5 −14.9 −18.5 −19.9 −32.0 −48.8
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −2.35 −0.82 −0.76 −0.76

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin5.4%Operating margin−403.8%Net margin−446.7%Free cash flow margin−398.3%Fiscal year 2017Gross margin21.2%Operating margin−298.2%Net margin−305.6%Free cash flow margin−303.8%Fiscal year 2018Gross margin27.6%Operating margin−211.4%Net margin−201.1%Free cash flow margin−213.1%Fiscal year 2019Gross margin20.3%Operating margin−263.8%Net margin−269.8%Free cash flow margin−271.3%Fiscal year 2020Gross margin3.3%Operating margin−417.7%Net margin−424.3%Free cash flow margin−369.0%Fiscal year 2021Gross margin16.8%Operating margin−327.4%Net margin−331.9%Free cash flow margin−301.5%Fiscal year 2022Gross margin21.6%Operating margin−361.9%Net margin−357.6%Free cash flow margin−309.7%Fiscal year 2023Gross margin29.1%Operating margin−340.7%Net margin−321.0%Free cash flow margin−270.1%Fiscal year 2024Gross margin21.5%Operating margin−478.0%Net margin−456.6%Free cash flow margin−332.0%Fiscal year 2025Gross margin29.5%Operating margin−552.6%Net margin−543.3%Free cash flow margin−409.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 5.4% 21.2% 27.6% 20.3% 3.3% 16.8% 21.6% 29.1% 21.5% 29.5%
Operating margin −403.8% −298.2% −211.4% −263.8% −417.7% −327.4% −361.9% −340.7% −478.0% −552.6%
Net margin −446.7% −305.6% −201.1% −269.8% −424.3% −331.9% −357.6% −321.0% −456.6% −543.3%
Free cash flow margin −398.3% −303.8% −213.1% −271.3% −369.0% −301.5% −309.7% −270.1% −332.0% −409.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−7.5Capital expenditure−0.0Free cash flow−7.5Fiscal year 2017Operating cash flow−8.1Capital expenditure−0.3Free cash flow−8.4Fiscal year 2018Operating cash flow−7.6Capital expenditure−0.1Free cash flow−7.7Fiscal year 2019Operating cash flow−9.8Capital expenditure−0.3Free cash flow−10.1Fiscal year 2020Operating cash flow−9.1Capital expenditure−0.1Free cash flow−9.2Fiscal year 2021Operating cash flow−13.2Capital expenditure−0.3Free cash flow−13.6Fiscal year 2022Operating cash flow−15.5Capital expenditure−0.5Free cash flow−16.0Fiscal year 2023Operating cash flow−16.4Capital expenditure−0.4Free cash flow−16.8Fiscal year 2024Operating cash flow−21.9Capital expenditure−1.4Free cash flow−23.3Fiscal year 2025Operating cash flow−35.1Capital expenditure−1.7Free cash flow−36.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −7.5 −8.1 −7.6 −9.8 −9.1 −13.2 −15.5 −16.4 −21.9 −35.1
Capital expenditure −0.0 −0.3 −0.1 −0.3 −0.1 −0.3 −0.5 −0.4 −1.4 −1.7
Free cash flow −7.5 −8.4 −7.7 −10.1 −9.2 −13.6 −16.0 −16.8 −23.3 −36.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash7.5Total debt2.7Net cash (debt)4.8Shareholders’ equity4.0Debt to equity0.66Fiscal year 2017Cash3.7Shareholders’ equity2.7Fiscal year 2018Cash9.4Shareholders’ equity8.8Fiscal year 2019Cash5.5Shareholders’ equity5.4Fiscal year 2020Cash12.6Shareholders’ equity12.2Fiscal year 2021Cash12.0Shareholders’ equity33.5Fiscal year 2022Cash4.6Shareholders’ equity17.4Fiscal year 2023Cash9.6Shareholders’ equity39.5Fiscal year 2024Cash18.9Shareholders’ equity36.1Fiscal year 2025Cash8.9Shareholders’ equity55.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.5 3.7 9.4 5.5 12.6 12.0 4.6 9.6 18.9 8.9
Total debt 2.7 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) 4.8 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 4.0 2.7 8.8 5.4 12.2 33.5 17.4 39.5 36.1 55.2
Debt to equity 0.66 n/a n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
1.9 2.8 3.6 3.7 2.5 4.5 5.2 6.2 7.0 9.0
Growth +45.8% +30.4% +3.3% −33.2% +80.9% +15.0% +20.0% +13.0% +28.1%
1.8 2.2 2.6 3.0 2.4 3.7 4.1 4.4 5.5 6.3
0.1 0.6 1.0 0.8 0.1 0.8 1.1 1.8 1.5 2.6
Growth +473.5% +70.1% −24.0% −89.0% +808.4% +48.1% +61.8% −16.7% +75.9%
1.3 1.3 1.5 3.0 2.2 5.2 7.8 8.0 13.6 15.0
5.0 5.2 4.8 5.2 6.1 7.4 8.4 11.1 15.3 20.7
−7.6 −8.2 −7.6 −9.8 −10.4 −14.7 −18.7 −21.1 −33.5 −49.6
Growth
−8.5 −8.4 −7.2 −10.0 −10.5 −14.9 −18.5 −19.9 −31.9 −48.7
0.0 0.0 n/a 0.0 0.0 0.0 0.0 0.1 0.1 0.1
−8.5 −8.4 −7.2 −10.0 −10.5 −14.9 −18.5 −19.9 −32.0 −48.8
Growth
Per share
n/a n/a n/a n/a n/a −2.03 −2.35 −0.82 −0.76 −0.76
n/a n/a n/a n/a n/a n/a −2.35 −0.82 −0.76 −0.76
Growth
n/a n/a n/a n/a n/a 7.3 7.9 24.3 41.9 64.3
n/a n/a n/a n/a n/a n/a 7.9 24.3 41.9 64.3
Growth +208.3% +72.8% +53.4%

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 29.3% a year over five years.
  • Operating margin is down 134.8 points on five years ago, at -552.6%.
  • A net loss in 10 of 10 years on file.